aXichem AB (FRA:A6X) Beta: -3.9368 (As of Jun. 28, 2026)


FRA:A6X aXichem AB FRA:A6X
50 GF Score
Price €0.10
GF Value €0.22
View Full Analysis

What is aXichem AB Beta?

aXichem AB FRA:A6X +12.20% 50 Beta is -3.9368 as of Jun. 28, 2026. GuruFocus rates FRA:A6X with a GF Score™ of 50/100 and a GF Value™ of €0.22.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), aXichem AB's Beta is -3.9368.


aXichem AB  (FRA:A6X) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


aXichem AB Beta Related Terms


aXichem AB Beta Historical Data

* Premium members only.

The historical data trend for aXichem AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

aXichem AB Beta Chart

aXichem AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.09 1.10 -1.10 -0.00 -0.87

aXichem AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.11 -1.91 -2.56 -0.87 -3.36

FRA:A6X vs LIN, SHW, ECL: Beta Comparison

For the Specialty Chemicals subindustry, aXichem AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aXichem AB Beta vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, aXichem AB's Beta distribution charts can be found below:

* The bar in red indicates where aXichem AB's Beta falls into.


FRA:A6X
50GF Score
aXichem AB FRA:A6X
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

aXichem AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -3.9368 mean?
aXichem AB (FRA:A6X) has a Beta of -3.9368 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for aXichem AB and its competitors.
Is aXichem AB's Beta too high?
aXichem AB's current Beta is -3.9368. Overall, aXichem AB has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Beta compare to LIN and SHW?
aXichem AB's Beta of -3.9368 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Chemicals company?
A good Beta depends on the Chemicals industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for aXichem AB and its competitors. aXichem AB's current Beta is -3.9368. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current Beta of -3.9368. The stock's GF Value™ is €0.22, compared to a current price of €0.10 — trading 53.2% below its estimated fair value. The current Beta is -3.9368. aXichem AB's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current Beta is -3.9368 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is aXichem AB (FRA:A6X) Overvalued in 2026?

Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued. The current stock price of €0.10 is trading 53.2% below its estimated GF Value™ of €0.22.

Key valuation signals for FRA:A6X:

  • Beta: -3.9368
  • GF Value™: €0.22 vs. price of €0.10 (53.2% below fair value)
  • GF Score™: 50/100

No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


aXichem AB Business Description

Other Exchanges AXIC A:Sweden
Address Sodergatan 26, Malmo, NOR, 211 34
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
50GF Score

Get the complete analysis for FRA:A6X

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.22
GF Value